Gefitinib ('Iressa', ZD1839) given in the 'Iressa' Expanded Access Programme in patients with non-small-cell lung cancer

被引：0
|
作者：
Chioni, A
Barbieri, F
Baldini, E
Orlandini, C
Ricci, S
Conte, PF
机构：
[1] Ciari Univ Hosp, Pisa, Italy
[2] Policlin Univ Hosp, Pisa, Italy
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
  • [21] Outcomes of patients with advanced non-small cell tung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access study
    Jänne, PA
    Gurubhagavatula, S
    Yeap, BY
    Lucca, J
    Ostler, P
    Skarin, AT
    Fidias, P
    Lynch, TJ
    Johnson, BE
    LUNG CANCER, 2004, 44 (02) : 221 - 230
  • [22] Gefitinib ('Iressa', ZD1839) in patients with brain metastases from non-small-cell lung cancer:: report of four cases
    Cappuzzo, F
    Ardizzoni, A
    Soto-Parra, H
    Gridelli, C
    Maione, P
    Tisea, M
    Calandri, C
    Bartolini, S
    Santoro, A
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S26
  • [23] Gefitinib ('Iressa', ZD1839) in patients with brain metastases from non-small-cell lung cancer:: report of four cases
    Cappuzzo, F
    Calandri, C
    Bartolini, S
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S26
  • [24] Symptom improvement following gefitinib ('Iressa', ZD1839) therapy in a pretreated patient with non-small-cell lung cancer
    Pavlakis, N
    BRITISH JOURNAL OF CANCER, 2003, 89 : S31 - S31
  • [25] Gefitinib ('Iressa', ZD1839) in special patient populations (elderly ≥70 years or performance status ≥2) with advanced non-small-cell lung cancer:: a case series report from the 'Iressa' Expanded Access Programme
    Gridelli, C
    Maione, P
    Rossi, A
    Guerriero, C
    Barzelloni, ML
    Ferrara, C
    BRITISH JOURNAL OF CANCER, 2003, 89 : S29 - S29
  • [26] Efficacy of gefitinib ('Iressa', ZD1839) in a patient with advanced non-small-cell lung cancer with metastatic spread to the brain
    Petruzelka, L
    Zemanova, M
    BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
  • [27] Symptom improvement following gefitinib ('Iressa', ZD1839) therapy in a pretreated patient with non-small-cell lung cancer
    Pavlakis, N
    BRITISH JOURNAL OF CANCER, 2003, 89 : S31 - S31
  • [28] Gefitinib ('IRESSA', ZD1839) in patients with non-small cell lung cancer (NSCLC): The Royal Marsden experience
    Maisey, NR
    Parton, M
    Harper-Wynne, C
    Sumpter, K
    Ashley, S
    Eisen, T
    O'Brien, M
    BRITISH JOURNAL OF CANCER, 2004, 91 : S15 - S15
  • [29] Activity of the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in refractory non-small-cell lung cancer
    Parra, HS
    Cavina, R
    Zucali, P
    Campagnoli, E
    Latteri, F
    Biancofiore, G
    Abbadessa, G
    Morenghi, E
    Santoro, A
    BRITISH JOURNAL OF CANCER, 2003, 89 : S33 - S33
  • [30] Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
    Kakiuchi, S
    Daigo, Y
    Ishikawa, N
    Furukawa, C
    Tsunoda, T
    Yano, S
    Nakagawa, K
    Tsuruo, T
    Kohno, N
    Fukuoka, M
    Sone, S
    Nakamura, Y
    HUMAN MOLECULAR GENETICS, 2004, 13 (24) : 3029 - 3043
12345